Long COVID Trial, Recruiting (NCT04448145)

Long COVID Trial, Recruiting NCT04448145 Sponsor: Columbia University Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT04448145 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have either tested positive for COVID-19 using a lab test (such as a PCR or antibody test), or you have had symptoms that felt like COVID-19 (such as fever, cough, or shortness of breath).
You have never been diagnosed with COVID-19 and have never received a COVID-19 vaccine (this applies to people joining as a comparison/negative group).
You are at least 7 years old.
If you are 18 or older, you may also be asked to provide semen or breast milk samples as part of the study.

Who may not be able to join:

You are under 7 years of age.
You have other health conditions that, in the opinion of the study doctor, might interfere with or affect the results of the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Yin, MD, MS, Associate Professor of Medicine

Phone: 212-305-7185

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04448145

Sponsor: Columbia University

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: 212-305-7185

More information: https://clinicaltrials.gov/study/NCT04448145

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have either tested positive for COVID-19 using a lab test (such as a PCR or antibody test), or you have had symptoms that felt like COVID-19 (such as fever, cough, or shortness of breath).
You have never been diagnosed with COVID-19 and have never received a COVID-19 vaccine (this applies to people joining as a comparison/negative group).
You are at least 7 years old.
If you are 18 or older, you may also be asked to provide semen or breast milk samples as part of the study.

Who may not be able to join:

You are under 7 years of age.
You have other health conditions that, in the opinion of the study doctor, might interfere with or affect the results of the study (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Columbia University

Registry

ClinicalTrials.gov

Start date

26 March 2020

Est. completion

1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Duration of SARS-CoV-2 viral persistence in naso/oropharyngeal samples; Duration of SARS-CoV-2 viral persistence in stool or rectal swab samples; Duration of SARS-CoV-2 viral persistence in semen samples; Duration of SARS-CoV-2 viral persistence in breast milk samples; Prevalence of cell immune responses; Duration of COVID-19 Symptoms; Prevalence of post-viral sequelae; Prevalence of SARS-CoV-2 persistence and bacterial/viral community structures

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov